Stocks · Health care · Pharmaceutical Preparations

Emergent BioSolutions Inc.

EBS Clue Score47
United States Fiscal year ends December CIK 0001367644 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Louis W Sullivan
10 May 2021
Director
Exercised, kept
10,305
$18.64
$192.09K
Zsolt Harsanyi
14 May 2020
Director
Exercised, kept
3,434
$18.64
$64.01K
Louis W Sullivan
7 May 2019
Director
Exercised, kept
7,893
$13.37
$105.53K
Adam Havey
7 Mar 2018
EVP, Business Operations
Exercised, kept
6,573
$22.03
$144.80K
Daniel Abdun-Nabi
27 Feb 2017
President & CEO
Exercised, kept
3,662
$30.63
$112.17K

What was left out

Form 4 filings counted 420
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 79
Sales at will 108
Transactions with no price 0
Shares from compensation/vesting 9,734,290
Sales filed before the plan box existed 97
History held since 21 Nov 2006